Bookeditors, Athanasios D. Gouliamos, John A. Andreou and Paris A. Kosmi.
Summary: Designed to promote teamwork between radiologists and clinical oncologists, this book covers the currently available imaging modalities of relevance in clinical oncology. Discusses and illustrates a broad spectrum of oncologic diseases on these modalities.
Contents:
Intro; Foreword; Preface; Acknowledgments; Contents; Part I: Introductory;
1: Molecular Imaging in Oncology: Hybrid Imaging and Personalized Therapy of Cancer; 1.1 Introduction; 1.1.1 Molecular Imaging: The Principle and Its Historical Development; 1.2 General Methods of Molecular Imaging; 1.2.1 External Probes; 1.2.2 Internal Probes; 1.3 Clinical Applications of Molecular Imaging; 1.3.1 Traditional Clinical Applications of MI; 1.3.2 Current Clinical Applications of MI; Contemporary Hybrid Imaging of Cancer; 1.3.3 Personalized Therapy of Cancer [5]; Cancer as a Genomic Problem Current Therapeutic Issues of CancerPersonalized Cancer Therapy (PCT); Personalized Cancer Therapy Requirements; Tasks for Molecular and Hybrid Imaging; Current Experience in Applying PCT; Current Specific Studies in Applying PCT; Future Directions; References;
2: Imaging Criteria for Tumor Treatment Response Evaluation; 2.1 The Response Evaluation Criteria of the World Health Organization; 2.2 The Response Evaluation Criteria in Solid Tumors; 2.3 The Revision 1.1 of RECIST [3]; 2.3.1 Aim of Guideline RECIST 1.1; 2.3.2 Assessment of Measurable Tumor Burden 2.3.3 Evaluation of Response to Therapy [3, 6-8]2.3.4 Evaluation of the Response of "Target Lesions"; 2.3.5 Evaluation of the Response of "Non-target" Lesions; 2.3.6 Evaluation of New Lesions; 2.3.7 Assessment of the Best Overall Response; 2.3.8 Recommendations and Guidelines for Performing Imaging Examinations; 2.3.8.1 Computed Tomography (CT); 2.3.8.2 Magnetic Resonance Imaging (MRI); 2.3.8.3 Ultrasonography (US); 2.3.8.4 Positron Emission Tomography (PET); 2.3.9 Limitations of RECIST 1.1; References;
3: Imaging in Radiation Therapy; 3.1 Introduction 3.2 Pre-treatment Evaluation3.3 Treatment Planning; 3.4 Image-Guided Radiation Therapy: Adaptive Radiotherapy; 3.5 The MR-Linac; 3.6 Post-treatment Outcome Evaluation; 3.7 Future Trends: Functional Image-Guided Dose Optimization or Dose Painting; References;
4: Interventional Radiology in Oncology; 4.1 Thermal Tumor Ablation; 4.1.1 Radiofrequency Ablation (RFA); 4.1.2 Microwave Ablation (MWA); 4.1.3 Cryoablation; 4.2 Liver Tumors; 4.2.1 Hepatocellular Carcinoma (HCC); 4.2.1.1 Complications; 4.2.1.2 Side Effects; 4.2.2 Liver Metastases; 4.2.3 Thermal Ablation of Renal Tumors 4.2.4 Thermal Ablation of Lung Tumors4.3 Irreversible Electroporation (IRE); 4.3.1 Chemoembolization; 4.3.1.1 Chemoembolization (Conventional TACE; c-TACE); 4.3.1.2 Embolization (Bland Embolization); 4.3.1.3 Drug-Eluting Bead Chemoembolization; 4.3.1.4 Common Considerations for Chemoembolization; 4.3.1.5 Results; 4.3.2 Radioembolization; 4.4 Palliative Procedures; 4.4.1 Indications for Esophageal Stent; 4.4.2 Percutaneous Biliary Drainage (PTBD) and Stent Insertion; 4.4.3 Percutaneous Nephrostomy and Ureteral Stent Insertion; 4.5 Biopsy; References